|
STAMBP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.069000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.322400E-01 |
| Normal-vs-Stage2 |
1.227790E-01 |
| Normal-vs-Stage3 |
3.796400E-02 |
| Normal-vs-Stage4 |
4.918800E-01 |
| Stage1-vs-Stage2 |
1.011010E-01 |
| Stage1-vs-Stage3 |
7.640300E-02 |
| Stage1-vs-Stage4 |
4.369000E-01 |
| Stage2-vs-Stage3 |
8.932400E-01 |
| Stage2-vs-Stage4 |
7.332200E-01 |
| Stage3-vs-Stage4 |
7.472800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.606390E-01 |
| Normal-vs-AfricanAmerican |
9.272200E-01 |
| Normal-vs-Asian |
6.035200E-01 |
| Caucasian-vs-AfricanAmerican |
2.997800E-01 |
| Caucasian-vs-Asian |
7.481400E-01 |
| AfricanAmerican-vs-Asian |
4.990600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.299800E-01 |
| Normal-vs-Female |
3.397200E-03 |
| Male-vs-Female |
2.122700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.300800E-01 |
| Normal-vs-Extreme_Weight |
5.576800E-01 |
| Normal-vs-Obese |
3.555600E-01 |
| Normal-vs-Extreme_Obese |
6.727800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.440000E-01 |
| Normal_Weight-vs-Obese |
4.492400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.800400E-01 |
| Extreme_Weight-vs-Obese |
1.922780E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.674800E-01 |
| Obese-vs-Extreme_Obese |
8.614200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.267020E-01 |
| Normal-vs-Age(41-60Yrs) |
8.070000E-02 |
| Normal-vs-Age(61-80Yrs) |
9.063200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.942400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.130000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.285550E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.934180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.342000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.203800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.825600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.997600E-01 |
| Normal-VS-Type2 PRCC |
2.183000E-01 |
| Normal-VS-KIRP CIMP |
2.379100E-03 |
| Normal-VS-Unclassified PRCC |
6.677800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.204000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.780900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.017700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.422450E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.713800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.758200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.657000E-01 |
| Normal-vs-N1 |
2.244400E-02 |
| Normal-vs-N2 |
9.859400E-01 |
| N0-vs-N1 |
2.404000E-02 |
| N0-vs-N2 |
9.414800E-01 |
| N1-vs-N2 |
3.316400E-01 |
|
|
